Fed. Circ. Judge Unsure IP At Heart Of $1.1B Juno Win Is Valid
The Federal Circuit's chief judge appeared receptive Tuesday to Kite Pharma's argument that a Juno Therapeutics drug patent is too broad to be valid, potentially calling into question Juno's more than...To view the full article, register now.
Already a subscriber? Click here to view full article